Issued on behalf of Avant Technologies Inc.VANCOUVER, BC, Dec. 31, 2025 /PRNewswire/ -- USA News Group News Commentary – Recent clinical trials achieving ...

Repeated insulin shots at the same site can seed amyloid; consider this diagnosis if absorption seems erratic or glucose control worsens with a persistent lump.

Excess abdominal fat, particularly visceral fat, actively triggers morning blood sugar spikes by causing liver insulin ...

The drug candidate aims to reduce fat and is being developed for use alongside existing GLP-1 receptor agonist therapies.

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical ...

GLP-1, a glucagon-like peptide-1 secreted in the small intestine, promotes insulin production in the pancreas, thereby ...

Belly fat often rises after 30 due to muscle loss, lower insulin sensitivity and hormonal shifts. A California-based ...

The body undergoes a number of physiological changes that results in slower metabolism and greater storage of fat, according to Dr Sethi.

New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested ...

A breakthrough in insulin delivery could one day spell an end to the invasive needles on which many people with diabetes rely. Using mice, minipigs, and lab-grown human skin samples, scientists have ...

NovoLog is a mealtime (rapid-acting) insulin. It’s a brand-name form of insulin aspart. For type 1 diabetes, you’ll typically inject NovoLog before your meals throughout the day. For type 2 diabetes, ...